This suggested that the upregulated TNFα signaling via NF-κB, as a compensatory survival signal, likely play a critical to promote MCL cell survival upon treatment HSP90 inhibition and therefore compromise the efficacy of anti-MCL activity of HSP90 inhibitors. The gene discussed is NFKB1; the disease is mantle cell lymphoma.